These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 34257427)

  • 1. Dietary carbohydrates and fats in nonalcoholic fatty liver disease.
    Yki-Järvinen H; Luukkonen PK; Hodson L; Moore JB
    Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):770-786. PubMed ID: 34257427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
    Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
    Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.
    Yki-Järvinen H
    Nutrients; 2015 Nov; 7(11):9127-38. PubMed ID: 26556368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?
    Hydes T; Alam U; Cuthbertson DJ
    Front Nutr; 2021; 8():640557. PubMed ID: 33665203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease.
    Sandby K; Geiker NRW; Dalamaga M; Grønbæk H; Magkos F
    Curr Obes Rep; 2021 Jun; 10(2):125-133. PubMed ID: 33580876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars.
    Parry SA; Rosqvist F; Mozes FE; Cornfield T; Hutchinson M; Piche ME; Hülsmeier AJ; Hornemann T; Dyson P; Hodson L
    Diabetes Care; 2020 May; 43(5):1134-1141. PubMed ID: 32165444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease.
    St-Jules DE; Watters CA
    Drug Metab Lett; 2015; 9(2):72-9. PubMed ID: 26343136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.
    DiStefano JK
    Cell Mol Life Sci; 2020 Jun; 77(11):2079-2090. PubMed ID: 31760464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
    Chiu S; Mulligan K; Schwarz JM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease.
    DiNicolantonio JJ; Lucan SC; O'Keefe JH
    Prog Cardiovasc Dis; 2016; 58(5):464-72. PubMed ID: 26586275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease.
    Parks E; Yki-Järvinen H; Hawkins M
    J Clin Invest; 2017 Feb; 127(2):454-456. PubMed ID: 28112684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.
    Park G; Jung S; Wellen KE; Jang C
    Exp Mol Med; 2021 May; 53(5):809-822. PubMed ID: 34017059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional regulation of hepatic de novo lipogenesis in humans.
    Cross E; Dearlove DJ; Hodson L
    Curr Opin Clin Nutr Metab Care; 2023 Mar; 26(2):65-71. PubMed ID: 36892956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
    Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
    Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
    Ter Horst KW; Serlie MJ
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets.
    Umpleby AM; Shojaee-Moradie F; Fielding B; Li X; Marino A; Alsini N; Isherwood C; Jackson N; Ahmad A; Stolinski M; Lovegrove JA; Johnsen S; Jeewaka R Mendis AS; Wright J; Wilinska ME; Hovorka R; Bell JD; Thomas EL; Frost GS; Griffin BA
    Clin Sci (Lond); 2017 Nov; 131(21):2561-2573. PubMed ID: 28923880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.
    Zivkovic AM; German JB; Sanyal AJ
    Am J Clin Nutr; 2007 Aug; 86(2):285-300. PubMed ID: 17684197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.